Metabolik Kemik Hastalıkları - Türkiye Endokrinoloji Metabolizma ...

Kemiğin Paget Hastalığı
Metabolik Kemik Hastalıkları
179
17. Seton M, Moses AM, Bode RK, Schwartz C. Paget’s disease of bone: The skeletal
distribution, complications, and quality of life as perceived by patients. Bone 2010;
doi. 10.1016/j.bone.2010.09.021.
18. Michou L, Brown JP. Genetics of bone diseases: Paget’s disease, fibrous dyplasia,
osteopetrosis, and osteogenesis imperfecta. Joint Bone Spine 2010, doi 10.1016/j.jbspin
2010.07.010.
19. Laurin N, Brown JP, Morisette J, Raymond V, Recurrent mutation of the gene encoding
sequestosome 1 (SQSTM1) /p62 in Paget’s disease of bone. Am J Hum Genet
70: 1582-1588, 2002.
20. Ralston SH, Pathogenesis of Paget’s disease of bone. Bone 43: 819-825, 2008.
21. Devogelaer JP, Bergmann P, Boutsen BY, Goemaere S, Kaufman JM, Reginster JY,
Rozenberg S, Boonen S, Management of patients with Paget’s disease: A consensus
document of the Belgian Bone Club. Osteoporosis International 19: 1109-1117, 2008.
22. Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, et al. Management of patients with
Paget’s disease: A consensus statement of the Belgian Bone Club (Consensus). Ost Int
2008; 19: 1109-17.
23. Brown JP. Treating Paget’s disease: When matters more than how. Nat Rev Rheumatol
2009; 5: 663-65.
24. Silverman SL. Paget disease of bone. Therapeutic options (Review). J Clin Rheumatol
2008; 14: 299-305.
25. Shoback D, Marcus R, Bikle D, Metabolic bone disease. Basic &Clinical Endocrinology.
7.baskı. (Eds. FS Greenspan, DG Gardner). New York, Chicago, Lange Medical Books/
McGraw-Hill, 2004; 295-361.
26. Reid IR, Hosking DJ. Bisphosphonates in Paget’s disease (review). Bone 2010; doi: 10.1016/
j.bone2010.09.002.
27. Altman RD, Paget’s disease of bone. Disorders of bone and mineral metabolism. 2.baskı.
(Eds: FL Coe, MJ Favus), Philadelphia, Lippincott Williams & Wilkins, 2002; 985-1020.
28. Singer FR. Paget disease: when to treat and when not to treat. Nat Rev Rheumatol
2009; 5: 483-9.
29. Langston AL, Ralston SH. Management of Paget’s disease of bone. Rheumatol
2004; 43: 955-9.
30. Singer FR, Krane SM, Paget’s disease of bone. 3.baskı. (Eds: LV Avioli, SM Krane),
San Diego, Academic Press, 1998; 545-605.
31. Reid I, Miller P, Lyles K, et al. Comparison of a single infusion of zoledronic acid with
risedronate for Paget’disease of bone. N Engl J Med 2005;353:898-908.
32. Hahn TJ, Metabolic bone disease. Manual of Endocrinology and Metabolism. 3.baskı.
(Eds: N. Lavin). Philadelphia, Lippincott Williams and Wilkins, 2002; 325-345.